# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-16-000164
Filing Date
2016-04-12
Accepted
2016-04-12 16:03:27
Documents
11
Period of Report
2016-04-12
Effectiveness Date
2016-04-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | lgnd-2016annualmeetingprox.htm | DEF 14A | 1234686
2 |  | a02bfceligandpharmacommo001.jpg | GRAPHIC | 229336
3 |  | a02bfceligandpharmacommo002.jpg | GRAPHIC | 102572
4 |  | a02bffbligandpharmanotic001.jpg | GRAPHIC | 207587
5 |  | a02bffbligandpharmanotic002.jpg | GRAPHIC | 168504
6 |  | image0.jpg | GRAPHIC | 9775
7 |  | image1a01.gif | GRAPHIC | 565
8 |  | image2.gif | GRAPHIC | 1174
9 |  | image3.gif | GRAPHIC | 612
10 |  | image4.gif | GRAPHIC | 431
11 |  | image5.jpg | GRAPHIC | 79797
| Complete submission text file | 0000886163-16-000164.txt |  | 2326048

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 161567293
SIC: 2834 Pharmaceutical Preparations